Modern Healthcare News
 
RSS feed

Pharmaceuticals news and information

News
McKesson sees rebound in acquisition, gains from hep C drug distribution
By Rachel Landen | October 29, 2014 | Basic Web Basic Web Subscription Details
McKesson Corp.'s earnings rebounded during the second quarter of its fiscal year as its Celesio acquisition and growth in market share helped the San Francisco-based company realize $469 million in net income. Being an authorized distributor of Sovaldi likely helped as well.
FULL STORY »
 

News
Sovaldi fuels triple-digit rises in Gilead revenue and profits
By Jaimy Lee | October 28, 2014 | Basic Web Basic Web Subscription Details
Drugmaker Gilead Sciences again reported record growth as sales of its hepatitis C blockbuster Sovaldi topped $2.8 billion in the third quarter of the year.
FULL STORY »
 

News
Merck sees weaker Q3 on divestitures, hepatitis drug competition
By Jaimy Lee | October 27, 2014 | Basic Web Basic Web Subscription Details
Merck & Co. sales fell 4% to $10.5 billion in the third quarter and profit tumbled 20% as the Whitehouse Station, N.J.-based drugmaker faced declining sales of some of its top-selling drugs and the loss of market exclusivity for others, the company reported.
FULL STORY »
 

News
Bristol-Myers Squibb sees Q3 sales fall while profits rise
By Jaimy Lee | October 24, 2014 | Basic Web Basic Web Subscription Details
Bristol-Myers Squibb, the New York-based drugmaker, said sales fell 4% to $3.9 billion in the third quarter of 2014 as three of its top-selling drugs reported double-digit declines in revenue.
FULL STORY »
 

Information
Ebola vaccine trials could start in Africa in January
USA Today | October 22, 2014
Trials of Ebola vaccines could begin as early as January in the West African countries most affected by the virus, a World Health Organization official said Tuesday. Although there are no approved vaccines or treatments for Ebola, experts have said that vaccines are the best hope of getting the...
FULL STORY »
 


Advertisement | View Media Kit

Information
Banned drugs still turning up in weight-loss supplements
National Public Radio | October 22, 2014
Americans spend about $4 billion a year on weight-loss supplements. And the Food and Drug Administration spends a lot of effort policing distributors who market fraudulent products that are tainted with unsafe, banned drugs. But a study published Tuesday finds that buyers should beware: Just...
FULL STORY »
 

News
Ebola crisis draws experimental drugs, along with ethical concerns
By Jaimy Lee | October 21, 2014 | Basic Web Basic Web Subscription Details
A few pharmaceutical and biotechnology manufacturers are evaluating the best ways to get their experimental Ebola drugs in the hands of doctors even as experts raise questions about the ethics and science behind using drugs that haven't gone through a randomized clinical trial.
FULL STORY »
 

News
Reform Update: Medicaid programs crafting limits on Harvoni usage
By Virgil Dickson | October 21, 2014 | Basic Web Basic Web Subscription Details
Which Medicaid beneficiaries will have access to Gilead Sciences' newest high-cost hepatitis C treatment, Harvoni, and when they'll get that access, now depends on prior-authorization criteria being hammered out by various state agencies. Most will likely limit Harvoni use to patients dealing with...
FULL STORY »
 

Information
Send nominations for Excellence in Governance Award
Modern Healthcare | October 18, 2014
Modern Healthcare is now accepting nominations for its inaugural Excellence in Governance awards for 2015.
FULL STORY »
 

Information
Canadian Ebola vaccine to begin testing
Associated Press | October 13, 2014
An experimental Canadian-made Ebola vaccine that has shown promise in tests on primates is beginning clinical trials on humans in the U.S.
FULL STORY »
 

Search ModernHealthcare.com:


 

Switch to the new Modern Healthcare Daily News app

For the best experience of ModernHealthcare.com on your iPad, switch to the new Modern Healthcare app — it's optimized for your device but there is no need to download.